加拿大 - 英文 - Health Canada

quest vitamins a div of purity life health products - calcium (calcium hvp chelate); phosphorus (phosphorus hvp chelate); ascorbic acid - tablet - 100mg; 50mg; 1g - calcium (calcium hvp chelate) 100mg; phosphorus (phosphorus hvp chelate) 50mg; ascorbic acid 1g - vitamins & minerals

加拿大 - 英文 - Health Canada

great earth companies, inc. - calcium (calcium hvp chelate, calcium gluconate, calcium carbonate, calcium citrate); magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate); vitamin d3 (cholecalciferol) - tablet - 300mg; 150mg; 100unit - calcium (calcium hvp chelate, calcium gluconate, calcium carbonate, calcium citrate) 300mg; magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate) 150mg; vitamin d3 (cholecalciferol) 100unit - vitamins & minerals

加拿大 - 英文 - Health Canada

natural factors nutritional products ltd. - magnesium (magnesium hvp chelate, magnesium oxide); potassium (potassium citrate); zinc (zinc citrate); calcium (calcium citrate, calcium carbonate, calcium hvp chelate, calcium phosphate) - tablet - 175mg; 10mg; 5mg; 350mg - magnesium (magnesium hvp chelate, magnesium oxide) 175mg; potassium (potassium citrate) 10mg; zinc (zinc citrate) 5mg; calcium (calcium citrate, calcium carbonate, calcium hvp chelate, calcium phosphate) 350mg - minerals

加拿大 - 英文 - Health Canada

usana health sciences inc. - calcium (calcium citrate); magnesium (magnesium hvp chelate); vitamin d3; silicon (silicon hvp chelate) - tablet - 135mg; 90mg; 40unit; 2.25mg - calcium (calcium citrate) 135mg; magnesium (magnesium hvp chelate) 90mg; vitamin d3 40unit; silicon (silicon hvp chelate) 2.25mg - vitamins & minerals

加拿大 - 英文 - Health Canada

herba lab inc. - calcium (calcium carbonate); magnesium (magnesium carbonate, magnesium hvp chelate); vitamin d - capsule - 230mg; 56mg; 400unit - calcium (calcium carbonate) 230mg; magnesium (magnesium carbonate, magnesium hvp chelate) 56mg; vitamin d 400unit - vitamins & minerals

美国 - 英文 - NLM (National Library of Medicine)

bryant ranch prepack - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium a

美国 - 英文 - NLM (National Library of Medicine)

pharmin usa, llc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd).

美国 - 英文 - NLM (National Library of Medicine)

atlantic biologicals corps - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. warnings and precautions (5.1) the effects of calcium acetate

美国 - 英文 - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a

美国 - 英文 - NLM (National Library of Medicine)

exelan pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.